Higher plasma GM-CSF and CXCL10 were reported in COVID-19 patients and could represent the dysregulated immune response in COVID-19 patients driving the longer duration of mechanical ventilation in severe pneumonia. This evidence concerns the gene CSF2 and COVID-19.